Assess the Safety and Efficacy of NKPL66 (CaPre™) in the Treatment of Mild-to-high Hypertriglyceridemia
Clinical trial NCT01516151 · COMPLETED
Trial details
- NCT number
- NCT01516151
- Sponsor
- Grace Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2013-05-01
- Enrollment
- 289
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.